Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciprian Jitaru

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cell Death Discovery|August 13, 2025
Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapiesDavid Kegyes, Andrei Tat, Alin Stefan Vizitiu, et al.
Journal of Cellular and Molecular Medicine|October 22, 2024
Single low-dose decitabine as frontline therapy of acute myeloid leukaemia, with venetoclax salvageCiprian Jitaru, Mareike Cathrina Peters, Lovisha Aggarwal, et al.
Journal of Cellular and Molecular Medicine|September 28, 2024
RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high-grade myelodysplastic syndromesDiana Gulei, Vlad Moisoiu, David Kegyes, et al.
Blood Reviews|November 29, 2025
CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseasesAdrian-Bogdan Tigu, Madalina Nistor, Diana Gulei, et al.
Annals of Translational Medicine|August 23, 2021
Current therapeutic approaches in the management of hemophilia-a consensus view by the Romanian Society of HematologyIonut Hotea, Melen Brinza, Cristina Blag, et al.
The Lancet. Oncology|February 2, 2024
Design and implementation of a humanitarian cancer care programme for Ukrainian refugees in Moldova and RomaniaHoria Vulpe, Artiom Minzatean, Irena Tocino, et al.
Journal of Hematology|November 4, 2024
Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World ExperienceCiprian Jitaru, Argyris Symeonidis, Sorina Badelita, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cell Death Discovery|August 13, 2025
Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapiesDavid Kegyes, Andrei Tat, Alin Stefan Vizitiu, et al.
Journal of Cellular and Molecular Medicine|October 22, 2024
Single low-dose decitabine as frontline therapy of acute myeloid leukaemia, with venetoclax salvageCiprian Jitaru, Mareike Cathrina Peters, Lovisha Aggarwal, et al.
Journal of Cellular and Molecular Medicine|September 28, 2024
RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high-grade myelodysplastic syndromesDiana Gulei, Vlad Moisoiu, David Kegyes, et al.
Blood Reviews|November 29, 2025
CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseasesAdrian-Bogdan Tigu, Madalina Nistor, Diana Gulei, et al.
Annals of Translational Medicine|August 23, 2021
Current therapeutic approaches in the management of hemophilia-a consensus view by the Romanian Society of HematologyIonut Hotea, Melen Brinza, Cristina Blag, et al.
The Lancet. Oncology|February 2, 2024
Design and implementation of a humanitarian cancer care programme for Ukrainian refugees in Moldova and RomaniaHoria Vulpe, Artiom Minzatean, Irena Tocino, et al.
Journal of Hematology|November 4, 2024
Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World ExperienceCiprian Jitaru, Argyris Symeonidis, Sorina Badelita, et al.
Pageof 2